© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 4, 297,
February 17, 1999
© 1999 Oxford University Press
IN THIS ISSUE |
Axillary lymph node dissection is an established component of the surgical treatment of
breast cancer, and it is an important procedure in cancer staging; however, it is associated with
unpleasant side effects. In a study involving 376 patients, Veronesi et al. (p. 368) have investigated a radioactive tracer-guided procedure to identify the sentinel lymph
node (i.e., the node first receiving lymph from the area of the breast containing the tumor) so that
it could be removed and examined as a means of predicting the status of the axilla. The
procedure identified the sentinel node
Tumor Cells in Bronchoalveolar Lavage Fluids
X-Chromosome Inactivation and Heritable Ovarian Cancer
Oltipraz and Metabolism of Aflatoxin B
Retinoids and Chemoprevention